FDA Inspection
Catalent Pharma Solutions LimitedCatalent Pharma Solutions Limited – FDA Inspection, Feb 20, 2020
Record Details
This FDA Inspection record concerns Catalent Pharma Solutions Limited, with an inspection on February 20, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 20, 2020
- Product Type
- Drugs
View Company Profile
ID · d589f12b-d6fc-49b3-8690-e8f522afef3e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1141164
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Catalent Pharma Solutions Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| October 10, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 23, 2018 | Not classified | Office of Inspections and Investigations | |
| July 26, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 20, 2018 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
Other documents for Catalent Pharma Solutions Limited
- FDA Inspection 1267053 - 2024-10-10
- FDA Inspection 1261182 - 2023-06-15
- FDA Inspection 1065786 - 2018-08-23
- FDA Inspection 1064287 - 2018-07-26
- FDA Inspection 1048918 - 2018-04-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.